Common heart attack drug has no benefits and may raise death risk for women, major study finds
The trial, which tracked more than 8,500 patients across Spain and Italy, found that beta blockers, long prescribed after heart attacks, offer no clear benefit for patients whose heart function is normal.
The trial, which tracked more than 8,500 patients across Spain and Italy, found that beta blockers, long prescribed after heart attacks, offer no clear benefit for patients whose heart function is normal.
What's Your Reaction?
